Literature DB >> 15902120

Cellular response to chemotherapy and radiation in cervical cancer.

Angela Saxena1, Catheryn Yashar, Douglas D Taylor, Cicek Gercel-Taylor.   

Abstract

Effect of irradiation alone and irradiation after 5-fluorouracil (5-FU), paclitaxel, or cisplatin (CDDP) was investigated in human cervical cell lines (CaSki, ME180, SiHa, and C33A). High-risk human papillomavirus (HPV) (+) CaSki and SiHa cells were the most resistant to CDDP, 5-FU, and radiation treatments. Radiation and CDDP and 5-FU resulted in decreased survival of HPV 16 and 18 (+) cells, whereas addition of paclitaxel to radiation treatments decreased killing. Enhanced killing of ME180 cells containing HPV39 sequences was demonstrated with chemoradiotherapy with all agents. HPV(-) C33A was more sensitive to radiation than the other cell lines, and the addition of chemotherapeutic agents did not result in significant change in cytotoxicity. Expression of survivin was inversely proportional to cell sensitivity to CDDP, 5-FU, and radiation. Constitutive AKT levels are the lowest in cell lines that are the most resistant to CDDP, 5-FU, and radiation. These data provide correlation of response to combined therapeutic modalities with HPV status of cervical cancer and expression of survivin and AKT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902120     DOI: 10.1016/j.ajog.2004.12.045

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Synergistic effects of cisplatin-caffeic acid induces apoptosis in human cervical cancer cells via the mitochondrial pathways.

Authors:  Amonrat Koraneekit; Temduang Limpaiboon; Arunnee Sangka; Patcharee Boonsiri; Sakda Daduang; Jureerut Daduang
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

2.  Alterations of microRNA expression patterns in human cervical carcinoma cells (Ca Ski) toward 1'S-1'-acetoxychavicol acetate and cisplatin.

Authors:  Neoh Hun Phuah; Lionel L A In; Mohamad Nurul Azmi; Halijah Ibrahim; Khalijah Awang; Noor Hasima Nagoor
Journal:  Reprod Sci       Date:  2012-09-25       Impact factor: 3.060

3.  Pelvic irradiation modulates the pharmacokinetics of cisplatin in the plasma and lymphatic system.

Authors:  Tung-Hu Tsai; Yu-Jen Chen; Mei-Ling Hou; Li-Ying Wang; Hung-Chi Tai; Chen-Hsi Hsieh
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

4.  HPV-type-specific response of cervical cancer cells to cisplatin after silencing replication licensing factor MCM4.

Authors:  Mitali Das; Shyam Babu Prasad; Suresh Singh Yadav; Arusha Modi; Sunita Singh; Satyajit Pradhan; Gopeshwar Narayan
Journal:  Tumour Biol       Date:  2015-07-19

5.  Knock down of p53 or its ubiquitin ligase E6AP does not affect the sensitivity of human papillomavirus-positive cervical cancer cells to cisplatin.

Authors:  Olga Michnov; Erich Solomayer; Tanja Fehm; Frank Stubenrauch; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2012-04-22       Impact factor: 6.166

6.  Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.

Authors:  Kanchan Vishnoi; Sutapa Mahata; Abhishek Tyagi; Arvind Pandey; Gaurav Verma; Mohit Jadli; Tejveer Singh; Sukh Mahendra Singh; Alok C Bharti
Journal:  Tumour Biol       Date:  2016-07-24

7.  Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT.

Authors:  Anjali K Gupta; John H Lee; Werner W Wilke; Harry Quon; Gareth Smith; Amit Maity; John M Buatti; Douglas R Spitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-01       Impact factor: 7.038

8.  Cellular levels of oxidative stress affect the response of cervical cancer cells to chemotherapeutic agents.

Authors:  Maria Filippova; Valery Filippov; Vonetta M Williams; Kangling Zhang; Anatolii Kokoza; Svetlana Bashkirova; Penelope Duerksen-Hughes
Journal:  Biomed Res Int       Date:  2014-11-16       Impact factor: 3.411

9.  Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells.

Authors:  Yanfang Li; Tao Liu; Cristina Ivan; Jie Huang; De-Yu Shen; John J Kavanagh; Robert C Bast; Siqing Fu; Wei Hu; Anil K Sood
Journal:  Front Oncol       Date:  2013-03-20       Impact factor: 6.244

Review 10.  Local Radiotherapy Affects Drug Pharmacokinetics-Exploration of a Neglected but Significant Uncertainty of Cancer Therapy.

Authors:  Yu-Jen Chen; Tung-Hu Tsai; Li-Ying Wang; Chen-Hsi Hsieh
Journal:  Technol Cancer Res Treat       Date:  2017-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.